Ionis Pharmaceuticals Inc. (IONS) is set to bring smile on the investors face as Analysts sets mean Target price of $58.06

At the end of the latest market close, Ionis Pharmaceuticals Inc. (IONS) was valued at $47.25. In that particular session, Stock kicked-off at the price of $44.37 while reaching the peak value of $46.15 and lowest value recorded on the day was $43.50. The stock current value is $43.65.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Recently in News on April 6, 2021, Ionis announces proposed private placement of convertible notes. Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it intends to offer, subject to market conditions and other factors, $500.0 million aggregate principal amount of Convertible Senior Notes due 2026 (the “notes”) in a private placement (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Ionis also intends to grant the initial purchasers of the notes an option to purchase, within the 13-day period beginning on, and including, the first date on which the notes are issued, up to an additional $75.0 million principal amount of notes. You can read further details here

A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .


Ionis Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $64.37 on 01/26/21, with the lowest value was $41.42 for the same time period, recorded on 03/25/21.

Ionis Pharmaceuticals Inc. (IONS) full year performance was -15.18%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Ionis Pharmaceuticals Inc. shares are logging -32.19% during the 52-week period from high price, and 5.38% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $41.42 and $64.37.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3675043 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Ionis Pharmaceuticals Inc. (IONS) recorded performance in the market was -22.80%, having the revenues showcasing -21.96% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 6.14B, as it employees total of 757 workers.

Specialists analysis on Ionis Pharmaceuticals Inc. (IONS)

During the last month, 9 analysts gave the Ionis Pharmaceuticals Inc. a BUY rating, 2 of the polled analysts branded the stock as an OVERWEIGHT, 7 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 4 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 54.03, with a change in the price was noted -6.53. In a similar fashion, Ionis Pharmaceuticals Inc. posted a movement of -13.01% for the period of last 100 days, recording 1,183,402 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for IONS is recording 0.98 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.62.

Trends and Technical analysis: Ionis Pharmaceuticals Inc. (IONS)

Raw Stochastic average of Ionis Pharmaceuticals Inc. in the period of last 50 days is set at 9.72%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 15.34%. In the last 20 days, the company’s Stochastic %K was 30.90% and its Stochastic %D was recorded 31.36%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -22.80%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -8.26%, alongside a downfall of -15.18% for the period of the last 12 months. The shares increased approximately by -2.37% in the 7-day charts and went up by -14.73% in the period of the last 30 days. Common stock shares were lifted by -21.96% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free


Please enter your comment!
Please enter your name here